Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Ceftolozane is a cephalosporin antibiotic used to treat complicated intra-abdominal infections in combination with metronidazole, complicated urinary tract infections, and hospital-acquired pneumonia. Ceftolozane is a semi-synthetic broad-spectrum fifth generation cephalosporin.
- Mechanism
- Curator reviewed · 4 references
Ceftolozane belongs to the cephalosporin class of antibacterial drugs. Ceftolozane exerts antibacterial effects, preventing the formation of cell walls that protect bacteria from injury and confer resistance to some antibiotics. Its antibacterial activity is also mediated through ceftolozane binding to penicillin-binding proteins (PBPs), which are required for peptidoglycan cross-linking for bacterial cell wall synthesis. As a result of cell wall synthesis inhibition, bacterial cells are killed, treating various infections. Ceftolozane has a particularly high affinity to the penicillin-binding proteins for Pseudomonas aeruginosa and Escherichia coli as well as Klebsiella pneumoniae and other enteric bacteria. In particular, a high affinity has been seen in vitro for penicillin-binding proteins 1b, 1c, 2, and 3 when compared to other antibiotics, ceftazidime and imipenem.
- Primary indication
- Ceftolozane is used in combination with tazobactam for the treatment of infections caused by designated susceptible microorganisms in adult and pediatric patients: - Complicated Intra-abdominal Infections (cIAI), used in combination with metronidazole - Complicated Urinary...Curator reviewed · 5 structured indications
- Formula / weight
- C23H30N12O8S2 · 666.69 g/mol (avg)
- First approval
- Canada, 2015 · United States, 2014 · European Union, 2020
- Code names
- CXA-101 · FR-264,205
- Brand names
- Zerbaxa
Resolves to
JHFNIHVVXRKLEF-DCZLAGFPSA-NSMILESCN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Ceftolozane, and which of those have an active Phase 3 trial?